Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction — Stella

Home/Breast Cancer Female/Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer Female trials

Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction

Trial locations(1 site)

South Korea

Seoul National University Hospital, Seoul

Key details

Sponsor

DOF Inc.

Enrollment target

~120 participants

Started

June 2024

Primary completion

December 2026

Age range

19 Years – 79 Years

Sex

Female only

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.